Kailera Therapeutics, Inc. Common Stock (KLRA) News

Latest headlines that mention KLRA, newest first · each headline opens the original publisher

KLRA quote

Last price: $10.00
Day change: -5.03%
Next earnings: 2026-11-11

Quote & chart Expected move Insider trading IV rank history

KLRA headlines

last 30 days

Investing.com 1d ago

Jefferies reiterates Buy on Kailera stock, cites obesity pipeline

General T3JEF KLRA

Investing.com 7d ago

Kailera presents phase 1 data for ribupatide at EASD meeting

General T3KLRA

Investing.com 8d ago

Kailera completes enrollment in phase 3 obesity drug trials

General T3KLRA

Seeking Alpha News 20d ago

Kailera Therapeutics: Hold Due To Need For Progress On Weight Loss Differentiation

General T2KLRA

Seeking Alpha News 21d ago

Kailera Therapeutics: An Outside Biotech Bet For The Next GLP-1 Obesity Drug Approval

General T2KLRA

Also mentioned with KLRA

30d

JEF1

Headlines that tag both tickers

KLRA news alerts

Get an alert by email or push when a new headline mentions KLRA.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.